14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.62 $2.30 Wednesday, 24th Apr 2024 CTMX stock ended at $1.63. This is 2.98% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 4.94% from a day low at $1.62 to a day high of $1.70.
90 days $1.38 $2.86
52 weeks $1.04 $2.86

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Jun 01, 2023 $1.67 $1.71 $1.65 $1.68 270 747
May 31, 2023 $1.67 $1.72 $1.64 $1.71 200 420
May 30, 2023 $1.76 $1.76 $1.67 $1.68 327 071
May 26, 2023 $1.73 $1.74 $1.70 $1.74 224 679
May 25, 2023 $1.80 $1.80 $1.69 $1.71 422 214
May 24, 2023 $1.87 $1.87 $1.76 $1.80 511 967
May 23, 2023 $1.89 $1.95 $1.82 $1.90 723 605
May 22, 2023 $1.88 $1.94 $1.87 $1.92 780 413
May 19, 2023 $1.83 $1.89 $1.83 $1.88 339 673
May 18, 2023 $1.77 $1.88 $1.77 $1.81 638 855
May 17, 2023 $1.75 $1.77 $1.73 $1.77 193 037
May 16, 2023 $1.78 $1.79 $1.75 $1.76 321 995
May 15, 2023 $1.78 $1.84 $1.75 $1.82 313 269
May 12, 2023 $1.80 $1.83 $1.77 $1.78 637 004
May 11, 2023 $1.80 $1.83 $1.72 $1.77 743 818
May 10, 2023 $1.78 $1.89 $1.72 $1.82 1 653 576
May 09, 2023 $1.66 $1.74 $1.64 $1.72 380 885
May 08, 2023 $1.72 $1.72 $1.68 $1.68 137 040
May 05, 2023 $1.70 $1.74 $1.66 $1.70 435 716
May 04, 2023 $1.66 $1.68 $1.61 $1.67 471 844
May 03, 2023 $1.65 $1.71 $1.64 $1.65 313 778
May 02, 2023 $1.72 $1.73 $1.64 $1.65 288 257
May 01, 2023 $1.63 $1.73 $1.63 $1.72 346 971
Apr 28, 2023 $1.58 $1.66 $1.56 $1.63 296 332
Apr 27, 2023 $1.58 $1.59 $1.54 $1.59 292 426
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT